跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 150 条关于
“sCD40L”
全部
150
临床试验
64
药物
71
机构
0
资讯
15
9个月前
Cellenkos' CK0804 Regulatory T Cell Therapy Shows Promise in JAK Inhibitor-Resistant Myelofibrosis
4个月前
Mesenchymal Stem Cell Therapy Shows Promise for Rare "Butterfly Skin" Disease in Spanish Clinical Trial
去年
Immune Checkpoint Inhibitors Equally Effective in Older and Younger Cancer Patients Despite Immune Phenotype Differences
11个月前
Tonix Pharmaceuticals Advances TNX-1500 Anti-CD40L Antibody for Transplant Rejection Prevention
3年前
SEA-CD40 Combo Shows Antitumor Activity in Pancreatic Cancer
2个月前
Spero Therapeutics Secures $105 Million Non-Dilutive Royalty Financing to Advance Anti-CD40L Antibody SP001
3个月前
Tonix Pharmaceuticals Reports Positive Phase 1 Data for TNX-1500 Anti-CD40L Antibody in Transplant Rejection Prevention
上个月
Spero Therapeutics Appoints Dr. Debra Jeske Zack as CMO to Lead Phase 2-Ready Anti-CD40L Antibody SP001
2个月前
Innovent and Spero Strike $1.1 Billion Deal for Third-Generation Anti-CD40L Antibody Targeting IgG4-RD and Sjögren's Disease
上个月
Samchundang Pharm Reaches Global Settlement in Eylea Biosimilar Patent Dispute, Clearing Path for SCD411 Commercialization
第 1 页,共 2 页
上一页
下一页